Rhelion Life Sciences Corp (RHEL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 19 | 13 | N/A | N/A | N/A |
| Accounts receivable | -170 | -46 | -41 | -101 | N/A |
| Other Working Capital | 422 | -253 | -299 | -239 | 153 |
| Other Operating Activity | -1,148 | -483 | -525 | -507 | -306 |
| Operating Cash Flow | $-877 | $-769 | $-866 | $-848 | $-153 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -31 | N/A | N/A | N/A |
| Purchase Of Investment | -100 | -50 | N/A | N/A | N/A |
| Sale Of Investment | 980 | 0 | 585 | 150 | N/A |
| Other Investing Activity | -3,285 | 0 | -233 | 1,804 | -803 |
| Investing Cash Flow | $-2,427 | $-81 | $352 | $1,954 | $-803 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 20,737 | 0 | 479 | 3,855 | N/A |
| Other Financing Activity | 2,322 | 5,619 | 83 | -313 | 2,916 |
| Financing Cash Flow | $23,059 | $5,619 | $562 | $3,542 | $2,916 |
| Beginning Cash Position | 11,430 | 6,661 | 6,613 | 1,963 | 4 |
| End Cash Position | 31,185 | 11,430 | 6,661 | 6,613 | 1,963 |
| Net Cash Flow | $19,756 | $4,769 | $49 | $4,649 | $1,960 |
| Free Cash Flow | |||||
| Operating Cash Flow | -877 | -769 | -866 | -848 | -153 |
| Capital Expenditure | -204 | -31 | N/A | N/A | N/A |
| Free Cash Flow | -1,081 | -800 | -866 | -848 | -153 |